Invention Publication
- Patent Title: USE OF A NITROGEN-CONTAINING BISPHOSPHONATE IN COMBINATION WITH A GLUCOCORTICOID IN PREVENTING OR TREATING VIRAL PNEUMONIA
-
Application No.: US17720255Application Date: 2022-04-13
-
Publication No.: US20230149429A1Publication Date: 2023-05-18
- Inventor: Bo Huang
- Applicant: INSTITUTE OF BASIC MEDICAL SCIENCES, CHINESE ACADEMY OF MEDICAL SCIENCES
- Applicant Address: CN Beijing
- Assignee: INSTITUTE OF BASIC MEDICAL SCIENCES, CHINESE ACADEMY OF MEDICAL SCIENCES
- Current Assignee: INSTITUTE OF BASIC MEDICAL SCIENCES, CHINESE ACADEMY OF MEDICAL SCIENCES
- Current Assignee Address: CN Beijing
- Priority: CN 21113682916 2021.11.18
- Main IPC: A61K31/663
- IPC: A61K31/663 ; A61K31/573 ; A61K31/575 ; A61K31/58 ; A61K31/675 ; A61K31/569 ; A61K9/00 ; A61P37/06 ; A61P31/14

Abstract:
Provided is use of a nitrogen-containing bisphosphonate in combination with a glucocorticoid in preventing or treating viral pneumonia. Specifically, provided is a nitrogen-containing bisphosphonate in combination with a glucocorticoid for use in treating or ameliorating coronavirus infections, the nitrogen-containing bisphosphonate is selected from the group consisting of pamidronate, alendronate, risedronate, ibandronate, zoledronate, minodronate and incadronate. The glucocorticoid is selected from the group consisting of dexamethasone, rimexolone, prednisolone, fluorometholone, hydrocortisone, mometasone, fluticasone, beclomethasone, flunisolide, triamcinolone, fluticasone propionate, beclomethasone dipropionate, budesonide and mometasone furoate.
Public/Granted literature
Information query